Vines Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Buy
495
+45
+10% +$46K 0.49% 39
2026
Q1
$414K Sell
450
-7
-2% -$7.1K 0.41% 44
2025
Q4
$491K Buy
+457
New +$437K 0.48% 39

Other funds holding LLY

Vines Capital Management's LLY Position: Q2 2026 in Review

Vines Capital Management increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $46K and bringing the position to 495 shares worth $594K. The position accounts for 0.49% of the portfolio, ranked #39.

Vines Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vines Capital Management held 495 shares of Eli Lilly worth $594K as of Q2 2026.
  • Vines Capital Management bought 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 0.49% of Vines Capital Management's portfolio in Q2 2026, its #39 holding.
  • Vines Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vines Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.